KKR & Co Inc (KKR) Releases Quarterly Earnings Results, Beats Estimates By $0.05 EPS

Share on StockTwits

KKR & Co Inc (NYSE:KKR) released its quarterly earnings results on Thursday, October 25th. The asset manager reported $0.60 EPS for the quarter, beating the consensus estimate of $0.55 by $0.05, MarketWatch Earnings reports. KKR & Co Inc had a net margin of 48.08% and a return on equity of 6.95%. The business had revenue of $491.50 million for the quarter, compared to analyst estimates of $401.39 million.

KKR & Co Inc stock traded down $0.47 during midday trading on Friday, hitting $21.83. 3,901,847 shares of the stock were exchanged, compared to its average volume of 5,484,603. KKR & Co Inc has a 1 year low of $19.11 and a 1 year high of $28.73. The company has a market capitalization of $11.55 billion, a price-to-earnings ratio of 9.17, a price-to-earnings-growth ratio of 0.96 and a beta of 1.63. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.01 and a quick ratio of 1.01.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, November 20th. Investors of record on Monday, November 5th will be paid a dividend of $0.125 per share. This represents a $0.50 annualized dividend and a yield of 2.29%. The ex-dividend date is Friday, November 2nd. KKR & Co Inc’s dividend payout ratio (DPR) is 21.01%.

A number of brokerages have weighed in on KKR. Zacks Investment Research lowered shares of KKR & Co Inc from a “hold” rating to a “strong sell” rating in a report on Tuesday, July 24th. Oppenheimer set a $35.00 price target on shares of KKR & Co Inc and gave the company a “buy” rating in a report on Tuesday, July 24th. Jefferies Financial Group reiterated a “buy” rating and issued a $32.00 price target on shares of KKR & Co Inc in a report on Friday, July 27th. Keefe, Bruyette & Woods reiterated a “buy” rating and issued a $35.00 price target on shares of KKR & Co Inc in a report on Friday, July 27th. Finally, Citigroup raised their target price on shares of KKR & Co Inc from $31.00 to $34.00 and gave the company a “buy” rating in a research note on Tuesday, July 31st. Five investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $29.87.

In other news, major shareholder Fund Holdings L.P. Kkr purchased 16,817 shares of the company’s stock in a transaction that occurred on Thursday, August 23rd. The shares were purchased at an average price of $15.79 per share, with a total value of $265,540.43. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders have purchased a total of 82,905 shares of company stock worth $1,265,698 in the last ninety days.

ILLEGAL ACTIVITY NOTICE: “KKR & Co Inc (KKR) Releases Quarterly Earnings Results, Beats Estimates By $0.05 EPS” was first posted by BBNS and is the property of of BBNS. If you are viewing this story on another site, it was illegally stolen and reposted in violation of international copyright and trademark legislation. The original version of this story can be viewed at https://baseballnewssource.com/2018/11/18/kkr-co-inc-kkr-posts-quarterly-earnings-results-beats-expectations-by-0-05-eps/2887423.html.

About KKR & Co Inc

KKR & Co L.P. is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, and middle market investments.

Read More: What are the risks of holding treasury bonds?

Earnings History for KKR & Co Inc (NYSE:KKR)

Receive News & Ratings for KKR & Co Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KKR & Co Inc and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.